{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:21:58Z","timestamp":1787505718314,"version":"build-2736575974"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.intimp.2024.112661","type":"journal-article","created":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T12:53:06Z","timestamp":1720961586000},"page":"112661","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Eudragit S100 coated iron oxide-chitosan nanocomposites for colon targeting of 5-aminosalicylic acid ameliorate ulcerative colitis by improving intestinal barrier function and inhibiting NLRP3 inflammasome"],"prefix":"10.1016","volume":"139","author":[{"given":"Dandan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7918-4839","authenticated-orcid":false,"given":"Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.intimp.2024.112661_b0005","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/ecco-jcc\/jjx008","article-title":"Third european-evidence-based consensus on diagnosis and management of ulcerative colitis. part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders","volume":"11","author":"Magro","year":"2017","journal-title":"J Crohns Colitis."},{"issue":"2","key":"10.1016\/j.intimp.2024.112661_b0010","doi-asserted-by":"crossref","first-page":"135","DOI":"10.7861\/clinmed.2021-0080","article-title":"Ulcerative colitis: an update","volume":"21","author":"Segal","year":"2021","journal-title":"Clin Med."},{"issue":"10114","key":"10.1016\/j.intimp.2024.112661_b0015","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.intimp.2024.112661_b0020","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.3748\/wjg.v24.i13.1464","article-title":"Fecal microbial dysbiosis in chinese patients with inflammatory bowel disease","volume":"24","author":"Ma","year":"2018","journal-title":"World J of Gastroenterol."},{"issue":"6","key":"10.1016\/j.intimp.2024.112661_b0025","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1053\/j.gastro.2004.01.063","article-title":"Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences","volume":"126","author":"Loftus","year":"2004","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.intimp.2024.112661_b0030","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/ncpgasthep0528","article-title":"Mechanisms of disease: pathogenesis of crohn's disease and ulcerative colitis","volume":"3","author":"Sartor","year":"2006","journal-title":"Nat Clin Pract Gastroenterol Hepatol."},{"issue":"11","key":"10.1016\/j.intimp.2024.112661_b0035","first-page":"686","article-title":"The intestinal barrier function and its involvement in digestive disease","volume":"107","author":"Salvo","year":"2015","journal-title":"Rev Esp Enferm Dig."},{"issue":"9","key":"10.1016\/j.intimp.2024.112661_b0040","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1023\/A:1018909527659","article-title":"Evaluation of the physicochemical properties and dissolution characteristics of mesalamine: relevance to controlled intestinal drug delivery","volume":"10","author":"French","year":"1993","journal-title":"Pharm Res."},{"key":"10.1016\/j.intimp.2024.112661_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.127360","article-title":"Exploring \u03b2-glucan as a micro-nano system for oral delivery targeted the colon","volume":"253","author":"Dong","year":"2023","journal-title":"Int J of Biol Macromo."},{"issue":"2","key":"10.1016\/j.intimp.2024.112661_b0050","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2174\/2211738505666170424122722","article-title":"Oral nano-delivery systems for colon targeting therapy","volume":"5","author":"Zhang","year":"2017","journal-title":"Pharm Nanotechnol."},{"key":"10.1016\/j.intimp.2024.112661_b0055","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s40199-018-0222-4","article-title":"A systematic review of nano formulation of natural products for the treatment of inflammatory bowel disease: drug delivery and pharmacological targets","volume":"26","author":"Taghipour","year":"2018","journal-title":"Daru"},{"issue":"1","key":"10.1016\/j.intimp.2024.112661_b0060","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/fcp.12594","article-title":"Oral drug delivery with nanoparticles into the gastrointestinal mucosa","volume":"35","author":"Liu","year":"2021","journal-title":"Fundam Clin Pharmacol."},{"issue":"5","key":"10.1016\/j.intimp.2024.112661_b0065","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.nano.2015.02.018","article-title":"Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue","volume":"11","author":"Hua","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.intimp.2024.112661_b0070","article-title":"Chitosan-5-aminosalicylic acid conjugates for colon-specific drug delivery: methods of preparation and in vitro evaluations","volume":"57","author":"Nalinbenjapun","year":"2020","journal-title":"J Drug Deliv Sci Tec."},{"issue":"3","key":"10.1016\/j.intimp.2024.112661_b0075","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/15533174.2016.1186064","article-title":"Synthesis, characterization, and in vitro anticancer evaluation of iron oxide\/chitosan nanocomposites","volume":"47","author":"Badry","year":"2017","journal-title":"Inorg Nano-Met Chem."},{"key":"10.1016\/j.intimp.2024.112661_b0080","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.carbpol.2018.06.106","article-title":"Mesalazine\/hydroxypropyl-\u03b2-cyclodextrin\/chitosan nanoparticles with sustained release and enhanced anti-inflammation activity","volume":"198","author":"Tang","year":"2018","journal-title":"Carbohydr Polym."},{"issue":"8","key":"10.1016\/j.intimp.2024.112661_b0085","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1080\/17425247.2018.1504017","article-title":"Recent advances in oral delivery of biologics: nanomedicine and physical modes of delivery","volume":"15","author":"Vllasaliu","year":"2018","journal-title":"Expert Opin Drug Deliv."},{"issue":"1","key":"10.1016\/j.intimp.2024.112661_b0090","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ejpb.2008.03.004","article-title":"Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in caco-2 cells","volume":"70","author":"Sadeghi","year":"2008","journal-title":"Eur J of Pharm Biopharm."},{"issue":"1","key":"10.1016\/j.intimp.2024.112661_b0095","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/10717544.2014.903534","article-title":"pH triggered delivery of curcumin from Eudragit-coated chitosan microspheres for inflammatory bowel","volume":"23","author":"Sareen","year":"2016","journal-title":"Drug Deliv."},{"issue":"1","key":"10.1016\/j.intimp.2024.112661_b0100","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1021\/acsbiomaterials.0c01312","article-title":"Dietary Fe3O4 nanozymes prevent the injury of neurons and blood-brain barrier integrity from cerebral ischemic stroke","volume":"7","author":"Yan","year":"2021","journal-title":"ACS Biomater Sci Eng"},{"issue":"12","key":"10.1016\/j.intimp.2024.112661_b0105","doi-asserted-by":"crossref","first-page":"2206934","DOI":"10.1002\/advs.202206934","article-title":"Antioxidant cascade nanoenzyme antagonize inflammatory pain by modulating MAPK\/P-65 signaling pathway","volume":"10","author":"Ling","year":"2023","journal-title":"Adv Sci."},{"issue":"3","key":"10.1016\/j.intimp.2024.112661_b0110","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1021\/am405009f","article-title":"Co3O4 nanoparticles with multi-enzyme activities and their application in immunohistochemical assay","volume":"6","author":"Dong","year":"2014","journal-title":"ACS Appl Mater Interfaces."},{"issue":"5","key":"10.1016\/j.intimp.2024.112661_b0115","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1021\/acs.bioconjchem.9b00171","article-title":"Catalytic mechanisms of nanozymes and their applications in biomedicine","volume":"30","author":"Dong","year":"2019","journal-title":"Bioconjug Chem."},{"issue":"7","key":"10.1016\/j.intimp.2024.112661_b0120","doi-asserted-by":"crossref","first-page":"6773","DOI":"10.1166\/jnn.2016.11374","article-title":"Doxorubicin-Loaded Eudragit-coated chitosan nanoparticles in the treatment of colon cancers","volume":"16","author":"Li","year":"2016","journal-title":"J Nanosci Nanotechno."},{"issue":"4","key":"10.1016\/j.intimp.2024.112661_b0125","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1208\/s12249-016-0594-z","article-title":"Eudragit S100-coated chitosan nanoparticles co-loading tat for enhanced oral colon absorption of insulin","volume":"18","author":"Chen","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.intimp.2024.112661_b0130","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.actbio.2020.09.017","article-title":"Colitis-targeted hybrid nanoparticles-in-microparticles system for the treatment of ulcerative colitis","volume":"116","author":"Naeem","year":"2020","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.intimp.2024.112661_b0135","doi-asserted-by":"crossref","first-page":"13684","DOI":"10.1038\/s41598-020-70291-9","article-title":"Magnetic resonance imaging of umbilical cord stem cells labeled with superparamagnetic iron oxide nanoparticles: effects of labelling and transplantation parameters","volume":"10","author":"Ohki","year":"2020","journal-title":"Sci Rep."},{"issue":"1","key":"10.1016\/j.intimp.2024.112661_b0140","doi-asserted-by":"crossref","first-page":"7850","DOI":"10.1038\/s41598-017-08092-w","article-title":"Assessing cell-nanoparticle interactions by high content imaging of biocompatible iron oxide nanoparticles as potential contrast agents for magnetic resonance imaging","volume":"7","author":"Hachani","year":"2017","journal-title":"Sci Rep."},{"issue":"11","key":"10.1016\/j.intimp.2024.112661_b0145","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.3390\/nano11112888","article-title":"Influence of coating and size of magnetic nanoparticles on cellular uptake for In vitro MRI","volume":"11","author":"Cort\u00e9s-Llanos","year":"2021","journal-title":"Nanomaterials"},{"key":"10.1016\/j.intimp.2024.112661_b0150","first-page":"1","article-title":"3-(1H-Benzo[d]imidazol-6-yl)-5-(4-fluorophenyl)-1,2,4-oxadiazole (DDO7232), a novel potent Nrf2\/ARE inducer, ameliorates DSS-induced murine colitis and protects NCM460 cells against oxidative stress via ERK1\/2 phosphorylation","volume":"2018","author":"Xu","year":"2018","journal-title":"Oxid Med Cell Longevity."},{"issue":"9","key":"10.1016\/j.intimp.2024.112661_b0155","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.gastrohep.2020.10.008","article-title":"Silencing LncRNA-DANCR attenuates inflammation and DSS-induced endothelial injury through miR-125b-5p","volume":"44","author":"Zhang","year":"2021","journal-title":"Gastroenterol Hepatol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112661_b0160","doi-asserted-by":"crossref","first-page":"26585","DOI":"10.1038\/srep26585","article-title":"An inhibitor of the Keap1-Nrf2 protein-protein interaction protects NCM460 colonic cells and alleviates experimental colitis","volume":"6","author":"Lu","year":"2016","journal-title":"Sci Rep."},{"issue":"10","key":"10.1016\/j.intimp.2024.112661_b0165","doi-asserted-by":"crossref","first-page":"956","DOI":"10.3390\/metabo12100956","article-title":"Paeonol ameliorates ulcerative colitis in mice by Modulating the Gut Microbiota and Metabolites","volume":"12","author":"Zheng","year":"2022","journal-title":"Metabolites"},{"issue":"23","key":"10.1016\/j.intimp.2024.112661_b0170","doi-asserted-by":"crossref","first-page":"10808","DOI":"10.7150\/thno.47601","article-title":"Oral delivery of anti-TNF antibody shielded by natural polyphenol-mediated supramolecular assembly for inflammatory bowel disease therapy","volume":"10","author":"Wang","year":"2020","journal-title":"Theranostics."},{"issue":"6","key":"10.1016\/j.intimp.2024.112661_b0175","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1080\/02652048.2021.1942275","article-title":"Nanoparticles in nanomedicine: a comprehensive updated review on current status, challenges and emerging opportunities","volume":"38","author":"Abdel-Mageed","year":"2021","journal-title":"J Microencapsul."},{"issue":"3","key":"10.1016\/j.intimp.2024.112661_b0180","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3892\/mmr.2017.6153","article-title":"5-ASA-loaded SiO2 nanoparticles-a novel drug delivery system targeting therapy on ulcerative colitis in mice","volume":"15","author":"Tang","year":"2017","journal-title":"Mol Med Rep."},{"issue":"9","key":"10.1016\/j.intimp.2024.112661_b0185","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1166\/jbt.2014.1229","article-title":"pH-sensitive Eudragit S-100 coated chitosan nanoparticles of 5-amino salicylic acid for colon delivery","volume":"4","author":"Mongia","year":"2014","journal-title":"J Biomater Tiss Eng."},{"issue":"5","key":"10.1016\/j.intimp.2024.112661_b0190","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1208\/s12249-023-02568-x","article-title":"Achillea wilhelmsii\u2013incorporated chitosan@Eudragit nanoparticles intended for enhanced ulcerative colitis treatment","volume":"24","author":"Malek","year":"2023","journal-title":"AAPS PharmSciTech"},{"issue":"6","key":"10.1016\/j.intimp.2024.112661_b0195","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1208\/s12249-022-02327-4","article-title":"Mucus-penetrating alginate-chitosan nanoparticles loaded with berberine hydrochloride for oral delivery to the inflammation site of ulcerative colitis","volume":"23","author":"Sun","year":"2022","journal-title":"AAPS PharmSciTech"},{"issue":"3","key":"10.1016\/j.intimp.2024.112661_b0200","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3390\/ma8030832","article-title":"Eudragit S100 coated citrus pectin nanoparticles for colon targeting of 5-fluorouracil","volume":"8","author":"Subudhi","year":"2015","journal-title":"Materials."},{"issue":"1","key":"10.1016\/j.intimp.2024.112661_b0205","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12906-020-02974-9","article-title":"Modified Pulsatillae decoction inhibits DSS-induced ulcerative colitis in vitro and in vivo via IL-6\/STAT3 pathway","volume":"20","author":"Huangfu","year":"2020","journal-title":"BMC Complement Med and Ther."},{"key":"10.1016\/j.intimp.2024.112661_b0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2021.104866","article-title":"Walnut oil alleviates DSS\u2013induced colitis in mice by inhibiting NLRP3 inflammasome activation and regulating gut microbiota","volume":"154","author":"Miao","year":"2021","journal-title":"Microb Pathog."},{"issue":"1","key":"10.1016\/j.intimp.2024.112661_b0215","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1080\/10717544.2017.1384521","article-title":"Characterization of brusatol self-microemulsifying drug delivery system and its therapeutic effect against dextran sodium sulfate-induced ulcerative colitis in mice","volume":"24","author":"Zhou","year":"2017","journal-title":"Drug Deliv."},{"issue":"1","key":"10.1016\/j.intimp.2024.112661_b0220","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/ecco-jcc\/jjz113","article-title":"Oral targeted delivery by nanoparticles enhances efficacy of an Hsp90 inhibitor by reducing systemic exposure in murine models of colitis and colitis-associated cancer","volume":"14","author":"Yang","year":"2020","journal-title":"J Crohns Colitis."},{"issue":"8","key":"10.1016\/j.intimp.2024.112661_b0225","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1093\/jn\/137.8.1931","article-title":"Dietary glutamine affects mucosal functions in rats with mild DSS-induced colitis","volume":"137","author":"Vicario","year":"2007","journal-title":"J Nutr."},{"key":"10.1016\/j.intimp.2024.112661_b0230","doi-asserted-by":"crossref","first-page":"79897","DOI":"10.3389\/fimmu.2021.679897","article-title":"Kaempferol alleviates murine experimental colitis by restoring gut microbiota and inhibiting the LPS-TLR4-NF-\u03baB axis","volume":"12","author":"Qu","year":"2021","journal-title":"Front in Immunol."},{"key":"10.1016\/j.intimp.2024.112661_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2019.154963","article-title":"Interleukin-38 is elevated in inflammatory bowel diseases and suppresses intestinal inflammation","volume":"127","author":"Xie","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2024.112661_b0240","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.freeradbiomed.2019.04.025","article-title":"Hydrogen sulfide protects against DSS-induced colitis by inhibiting NLRP3 inflammasome","volume":"137","author":"Qin","year":"2019","journal-title":"Free Radic Biol Med."},{"issue":"2","key":"10.1016\/j.intimp.2024.112661_b0245","doi-asserted-by":"crossref","first-page":"528","DOI":"10.7150\/thno.87739","article-title":"Targeted modulation of intestinal epithelial regeneration and immune response in ulcerative colitis using dual-targeting bilirubin nanoparticles","volume":"14","author":"Zhuo","year":"2024","journal-title":"Theranostics."},{"issue":"1","key":"10.1016\/j.intimp.2024.112661_b0250","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12951-022-01421-w","article-title":"Oral administration of turmeric-derived exosome-like nanovesicles with anti-inflammatory and pro-resolving bioactions for murine colitis therapy","volume":"20","author":"Liu","year":"2022","journal-title":"J Nanobiotechnology."},{"issue":"11","key":"10.1016\/j.intimp.2024.112661_b0255","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.3109\/10715762.2012.717692","article-title":"Oxidative stress in ulcerative colitis: an old concept but a new concern","volume":"46","author":"Jena","year":"2012","journal-title":"Free Radic Res."},{"key":"10.1016\/j.intimp.2024.112661_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102469","article-title":"MPST deficiency promotes intestinal epithelial cell apoptosis and aggravates inflammatory bowel disease via AKT","volume":"56","author":"Zhang","year":"2022","journal-title":"Redox Biol."},{"issue":"4","key":"10.1016\/j.intimp.2024.112661_b0265","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.jcmgh.2020.12.013","article-title":"Preventing colitis-associated colon cancer with antioxidants: a systematic review","volume":"11","author":"Irrazabal","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol."},{"issue":"12","key":"10.1016\/j.intimp.2024.112661_b0270","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.3390\/nu15122746","article-title":"The protective effect of heat-inactivated companilactobacillus crustorum on dextran sulfate sodium-induced ulcerative colitis in mice","volume":"15","author":"Zhong","year":"2023","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.intimp.2024.112661_b0275","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a029314","article-title":"Cell biology of tight junction barrier regulation and mucosal disease","volume":"10","author":"Buckley","year":"2018","journal-title":"Cold Spring Harb Perspect Biol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112661_b0280","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1080\/21655979.2021.2012549","article-title":"Transcription factor paired related homeobox 1 (PRRX1) activates matrix metalloproteinases (MMP)13, which promotes the dextran sulfate sodium-induced inflammation and barrier dysfunction of NCM460 cells","volume":"13","author":"Zhang","year":"2022","journal-title":"Bioengineered."},{"key":"10.1016\/j.intimp.2024.112661_b0285","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.767456","article-title":"IL-1\u03b2 and the intestinal epithelial tight junction barrier","volume":"12","author":"Kaminsky","year":"2021","journal-title":"Front Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2024.112661_b0290","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1007\/s10753-019-01085-z","article-title":"Paeoniflorin prevents intestinal barrier disruption and inhibits lipopolysaccharide (LPS)-induced inflammation in Caco-2 cell monolayers","volume":"42","author":"Wu","year":"2019","journal-title":"Inflammation"},{"issue":"9","key":"10.1016\/j.intimp.2024.112661_b0295","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.3390\/antiox11091674","article-title":"Mulberry anthocyanins ameliorate DSS-induced ulcerative colitis by improving intestinal barrier function and modulating gut microbiota","volume":"11","author":"Mo","year":"2022","journal-title":"Antioxidants."},{"key":"10.1016\/j.intimp.2024.112661_b0300","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.ijbiomac.2020.10.259","article-title":"Scutellaria baicalensis Georgi polysaccharide ameliorates DSS-induced ulcerative colitis by improving intestinal barrier function and modulating gut microbiota","volume":"166","author":"Cui","year":"2021","journal-title":"Int J Biol Macromol."},{"key":"10.1016\/j.intimp.2024.112661_b0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108015","article-title":"Dioscin prevents DSS-induced colitis in mice with enhancing intestinal barrier function and reducing colon inflammation","volume":"99","author":"Cai","year":"2021","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.intimp.2024.112661_b0310","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.777665","article-title":"Lactic acid-producing probiotic saccharomyces cerevisiae attenuates ulcerative colitis via suppressing macrophage pyroptosis and modulating gut microbiota","volume":"12","author":"Sun","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.intimp.2024.112661_b0315","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ijbiomac.2022.01.049","article-title":"Chitin derivatives ameliorate DSS-induced ulcerative colitis by changing gut microbiota and restoring intestinal barrier function","volume":"202","author":"Mei","year":"2022","journal-title":"Int J Biol Macromol."},{"key":"10.1016\/j.intimp.2024.112661_b0320","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ijbiomac.2022.04.028","article-title":"Selenium-containing tea polsaccharides ameliorate DSS-induced ulcerative colitis via enhancing the intestinal barrier and regulating the gut microbiota","volume":"209","author":"Zhao","year":"2022","journal-title":"Int J of Biol Macromol."},{"key":"10.1016\/j.intimp.2024.112661_b0325","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12989-016-0162-4","article-title":"The NLRP3 inflammasome in pathogenic particle and fibre-associated lung inflammation and diseases","volume":"13","author":"Sayan","year":"2016","journal-title":"Part Fibre Toxicol."},{"key":"10.1016\/j.intimp.2024.112661_b0330","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.3390\/molecules25102427","article-title":"Does NLRP3 inflammasome and aryl hydrocarbon receptor play an interlinked role in bowel inflammation and colitis-associated colorectal cancer?","volume":"25","author":"Ngui","year":"2020","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.intimp.2024.112661_b0335","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1136\/gut.2009.197822","article-title":"Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome","volume":"59","author":"Bauer","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.intimp.2024.112661_b0340","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.molimm.2018.10.015","article-title":"Palmatine attenuated dextran sulfate sodium (DSS)-induced colitis via promoting mitophagy-mediated NLRP3 inflammasome inactivation","volume":"105","author":"Mai","year":"2019","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.intimp.2024.112661_b0345","article-title":"C646 protects against DSS-induced colitis model by targeting NLRP3 inflammasome","volume":"12","author":"Xu","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2024.112661_b0350","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3390\/biom11020162","article-title":"Anti-inflammatory effects of rosmarinic acid-loaded nanovesicles in acute colitis through modulation of NLRP3 inflammasome","volume":"11","author":"Marinho","year":"2021","journal-title":"Biomolecules"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924011822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924011822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T02:21:17Z","timestamp":1732933277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924011822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":70,"alternative-id":["S1567576924011822"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112661","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eudragit S100 coated iron oxide-chitosan nanocomposites for colon targeting of 5-aminosalicylic acid ameliorate ulcerative colitis by improving intestinal barrier function and inhibiting NLRP3 inflammasome","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112661","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"112661"}}